InsiderTrades.com logo
Man Who Picked Tesla, Bitcoin Makes Next “Pick of the Decade"
From Legacy Research   |   Ad
Picking the right “investment of the decade” can transform your life…

Today, the Wall Street legend who picked the last “investment of the decade”… months (even years) before his peers… will finally reveal his new #1 pick for the 2020s.

It’s not 5G, artificial intelligence, EVs, or clean energy. The answer will surprise you.
Click To See This #1 Pick.

IMC Insider Trading (Immuron)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$17,028.00
Insider Selling (Last 12 Months): A$1,305,660.10

Immuron Insider Trading History Chart

Immuron Share Price & Price History

A$0.00
+0.30 (1.20%)
As of 05/13/2020 01:00 AM ET
"I've never seen anything bigger"
From Legacy Research   |   Ad
According to one Wall Street Legend, "for those who take early action, it could make 2021 one of your best years ever".
Watch more here!

Immuron Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/9/2021Ravi SavarirayanInsiderExercise900,000A$0.23A$207,000.00
6/23/2020Roger AstonInsiderBuy56,760A$0.30A$17,028.00
6/17/2020Peter AnastasiouInsiderSell4,184,808A$0.31A$1,305,660.10
6/11/2020Daniel PollockInsiderSell100,000A$0.41A$40,500.00
7/19/2019Gary JacobInsiderBuy260,000A$0.08A$21,060.00
6/19/2019Daniel PollockInsiderBuy75,000A$0.11A$7,875.00
6/3/2019Daniel PollockInsiderBuy70,000A$0.14A$9,520.00
5/28/2019Peter AnastasiouInsiderBuy500,000A$0.16A$77,500.00
See Full Table
Immuron Limited, a biopharmaceutical company, researches and develops oral immunotherapy polyclonal antibodies for the treatment and prevention of infectious and immune modulated diseases in Australia, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. The company markets Travelan and Protectyn for the prevention of travellers' diarrhea. Its lead product candidates include IMM-124E that is in Phase II clinical trials for non-alcoholic steatohepatitis, severe alcoholic hepatitis, and non-alcoholic fatty liver disease, as well as used in antiviral activity against the COVID-19 virus in laboratory studies; and IMM-529, a clinical stage product for clostridium difficile infections. Immuron Limited was founded in 1994 and is based in Carlton, Australia.
Read More on Immuron

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

175,856 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Immuron?

Immuron's top insider investors include:
  1. Daniel Pollock (Insider)
  2. Gary Jacob (Insider)
  3. Peter Anastasiou (Insider)
  4. Ravi Savarirayan (Insider)
  5. Roger Aston (Insider)
Man Who Picked Tesla, Bitcoin Makes Next “Pick of the Decade"
From Legacy Research   |   Ad
Picking the right “investment of the decade” can transform your life…

Today, the Wall Street legend who picked the last “investment of the decade”… months (even years) before his peers… will finally reveal his new #1 pick for the 2020s.

It’s not 5G, artificial intelligence, EVs, or clean energy. The answer will surprise you.
Click To See This #1 Pick.